MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
27 hedge funds and large institutions have $13M invested in Marinus Pharmaceuticals, Inc in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+4
Holders Change %
+17.39%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NC
Nexthera Capital
New York
|
$1.42M |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
$1.37M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.16M |
| 4 |
Jennison Associates
New York
|
$690K |
| 5 |
BlackRock
New York
|
$416K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | -$11K | -2,712 | Closed |
|
|
NFG
27
Next Financial Group
Houston,
Texas
| – | -$3K | -668 | Closed |
|